Funding to Fuel Expansion of Mealogic’s Meal Delivery Platform, Helping Companies Launch Prepared Meal Delivery Programs that Drive Positive Health Outcomes and New Revenue Streams
WASHINGTON – June 18, 2025 – Mealogic, a leading ready-to-eat B2B2C meal delivery platform that enables companies of all types – including healthcare providers, wellness brands, and clinical programs – to unlock new revenue streams and deliver curated meals that meet specific nutritional standards, today announced that it has secured $16 million in funding to support the company’s rapid growth. The capital will enable Mealogic to deepen its end-to-end customer experience, scale business development, and expand access to convenient, high-quality, personalized nutrition solutions that support both the prevention and reversal of diet-related disease.
Mealogic attracted support from mission-aligned investors committed to improving health through food, including S2G Investments (lead investor), a multi-stage firm with a dedicated food and agriculture strategy, Dohmen Company Foundation, whose vision is life without diet-related disease, U.S. Venture Partners, and Unilever Ventures. Backed by this new investment, Mealogic is uniquely positioned to strengthen and expand the Food as Medicine market by further enabling both emerging and established organizations to deliver nutritious meals tailored to specific dietary standards.
“With strong investor backing and a bold vision, we’re entering a new chapter,” said Ryan Shadrick Wilson, Mealogic’s Executive Chairperson, “Launching a high-quality meal delivery program is hard, but Mealogic makes it easy. And now with a new leader and new capital, the company is ready for meaningful scale.”
“Mealogic is designed to be the engine behind today’s leading Food as Medicine companies,” said Derek Mansfield, CEO of Mealogic. “Our platform allows partners to deliver high-quality meals that reflect their unique dietary programs – whether they’re focused on metabolic health, complementing GLP-1 protocols, or any myriad of other nutrition-focused plans. We handle everything from e-commerce to food production to delivery, which frees up our partners to focus on growth, innovation, and the communities they serve. With more than 40 clients and over 25 science-backed dietary protocols, Mealogic is helping advance both prevention and treatment for diet-related health challenges.”
Unlike direct-to-consumer meal services, Mealogic operates as a white-label platform, enabling healthcare providers, wellness brands, and clinical programs to deliver curated meals that meet specific nutritional standards – such as low sodium, plant-based, or anti-inflammatory – under their own brand. Using a catalog of more than 5,000 nutritionally profiled meals, Mealogic’s system filters options based on each partner’s dietary requirements and handles everything from menu development and payment processing to production, delivery, and customer service.
Mealogic partners with a diverse network of producers across the country to ensure meals are not only health-supportive, but also fresh, locally sourced, culturally authentic, and rich in variety. Each week, the company offers more than 200 unique science-backed dishes designed to support positive health outcomes. With its seamless integration and turnkey model, Mealogic makes it easier for both emerging and established players to enter and scale within the Food as Medicine and healthy prepared meals market.
“Mealogic sits at the convergence of two of the most critical systems we believe we need to transform: food and health,” said Dan Ripma, Vice President at S2G Investments. “At a time when chronic conditions are surging and healthcare costs continue to climb, Mealogic offers providers a scalable, effective way to drive better outcomes through food. Many of our brand partners have shared that the platform has helped them reach new audiences and unlock additional revenue. In our view, it’s exactly the kind of solution needed to address today’s urgent health challenges and build a more sustainable, equitable food system.”
“The Dohmen Company Foundation is committed to strengthening the Food as Medicine ecosystem by supporting organizations like Mealogic that make it easier for providers and entrepreneurs to enter, grow, and thrive in this critical space,” said Rachel Roller, President and CEO of the Dohmen Company Foundation. “From startups to national healthcare systems, Mealogic offers the infrastructure needed to bring nutrition-forward meal programs to life. That kind of enablement is exactly what our country needs right now – a vibrant, expanding market of efficacious food-based health solutions that can reach more people, more effectively.”
The funding comes as Mealogic welcomes new leadership. Mansfield, who stepped into the CEO role earlier this year, brings a vision focused on impact, scalability, and strategic partnerships.
“We envision a future where food-based care is seamlessly integrated into everyday health, and we’re building the infrastructure to make that future possible,” said Mansfield.
About Mealogic:
For businesses looking to expand their impact and revenue through personalized nutrition, Mealogic offers a seamless solution. Mealogic empowers businesses to deliver chef-crafted, nutrition-led meals serving over 25 specialty dietary protocols. Our turnkey platform combines an end-to-end ecommerce experience, a diverse national chef network, and best-in-class delivery services. Transform your community’s nutrition journey with us. Get started at Mealogic.com.
About S2G Investments:
S2G is a multi-stage investment firm focused on venture and growth-stage businesses across food & agriculture, oceans, and energy. The firm provides capital and value-added resources to companies and leadership teams pursuing market-based solutions designed to deliver greater value, improved outcomes, and enhanced performance over traditional alternatives. With a commitment to creating long-term, measurable outcomes, S2G structures flexible capital solutions that can range from venture funding through growth equity to debt and infrastructure financing. For more information about S2G, visit s2ginvestments.com or connect with us on LinkedIn.
About Dohmen Company Foundation:
With more than 165 years of healthcare experience, Dohmen has found a way to combine the rigor of business with the heart of philanthropy. After exiting the life science industry in 2018, Dohmen shareholders transformed the multi-generational family-owned business to a private foundation. Today, the Dohmen Company Foundation advances its vision of life without diet-related disease in three powerful ways: via its investment fund focused on accelerating the growth of for-profit social businesses with proven food solutions that improve human health, via traditional grant making dedicated to increasing the impact of charitable organizations aligned with our vision, and through public awareness of the surging rates of diet-related disease that threaten our national wellbeing. For more information, please visit dohmencompanyfoundation.org.
About U.S. Venture Partners:
U.S. Venture Partners (USVP) is a leading Silicon Valley venture capital firm, partnering with entrepreneurs to transform their ideas into world-changing companies. USVP has invested in over 500 companies spanning four decades, including: Arkose Labs, Box, Carrot Fertility, Cato Networks, Check Point Software, Guidewire, Happy Returns, HeartFlow, HotelTonight, Human Interest, Imperva, Inari Medical, Inspire Medical Systems, Intersect ENT, Kenna, Medigate, Omada Health, Pluto TV, Standard Bariatrics, ThreatMetrix, Trunk Club, Trusteer, Yammer and Zerto. USVP focuses on early-stage start-ups that transform cybersecurity, enterprise software, consumer and healthcare. The USVP team consists of former entrepreneurs, technologists, corporate executives, and financial professionals who assist with strategy, scaling, team building, product development, and business development. USVP is based in Menlo Park, California. More information can be found at www.usvp.com.
About Unilever Ventures:
Unilever Ventures, the venture and growth capital arm of Unilever, partners with entrepreneurs with ground-breaking ideas and ambitions to transform the world. Our mission extends beyond mere capital provision; we enable these visionaries to cultivate distinctive brands and innovative technology solutions that resonate on a global scale. Our investment focuses on both early-stage and growth opportunities that lie at the crossroads of consumer goods, commerce, and technology, primarily in North America, Europe, and Asia. For further information, please visit www.unileverventures.com.
